NewswireToday - /newswire/ -
Bangalore, Karnataka, India, 2009/10/07 - Strand announces, product management veteran “Thon de Boer”, as its Sr. Director - Product Management.
Strand Life Sciences, Pioneers in Discovery Research Informatics, today announced that, “Thon de Boer” former Sr. Product Manager-Bioinformatics at Complete Genomics and Product manager for GeneSpring family of products, at Agilent Technology has joined Strand as the company's Sr. Director of Product Management, Software.
This newly created product management role is designed to expand on Strand’s current leadership position in innovation through an increased rate of new product introductions and expanded R&D programs. His primary responsibilities at Strand will include managing and expanding Strand’s software product portfolio activities from concept to customer and providing strategic direction for software product development.
"We are pleased to welcome Thon as a member of our Sr. management team, "said said Francois Mandeville, Executive Vice President, Strand Life Sciences.” Thon has unparalleled expertise and experience in Bioinformatics Product Development and Programming and in-depth knowledge of many Bioinformatics software solution and we are confident that his addition to our team will be invaluable as we continue to expand our footprint on a global basis to meet increasing customer demand."
Thon’s outstanding resume includes over 14 years of hands-on experience in product management, as a researcher and manager in both international research institutes and commercial enterprises. Thon is an undergraduate in Biology and a Ph.D. in Molecular Biology from VU University, Amsterdam. He has been instrumental in the success of many of the standard software applications that are being used in thousands of labs all around the world and has a passion in making the complex algorithms used in modern Biology accessible to everyone.
About Strand Life Sciences
Strand Life Sciences – Pioneers in Discovery Research Informatics, is an innovative life science informatics company. Strand (strandls.com) has developed pioneering software technologies with applications in pharmaceutical drug discovery. Over the years Strand has built strong competencies and intellectual property in the areas of omics-based technologies, bioinformatics, cheminformatics, predictive modeling, workflow and knowledge management.
With a deep understanding of the life sciences industry, commitment to innovation, access to current and emerging technologies, mature development processes, global resources and a proven track record, Strand provides discovery informatics solutions and services and help its customers achieve their objectives.
Five of the top ten pharmaceutical companies, three of the top six biotechnology companies, and numerous academic institutions across the globe, are part of Strand's esteemed customer profile, who trust Strand for delivering solutions to complex problems in life sciences research. Strand is a portfolio company of UTI Venture Funds, Sequoia Capital, and MediBIC group (Japan).